Bruce Hamilton

Bruce Hamilton is an experienced leader in the biopharmaceutical industry with expertise in production and quality control of antibody-based products. Hamilton holds a Ph.D. in Biochemistry from The University of Manchester and an MSc in Biochemistry from the University of Oxford. He currently serves as the Director of Biopharmaceutical Development at Covance, having previously held leadership roles at Abcam, MedImmune, Bicycle Therapeutics, Domantis/GSK, and GlaxoSmithKline. Hamilton began his research career as a Research Scientist at GlaxoSmithKline and has since become a trusted investigator with valuable insights into the field.